New blood: award-winning investment

Researchers created the Leeds University Next-Generation AntiCoagulant (LUNAC) Therapeutics, focused on developing the “holy grail” of anticoagulant treatments – providing high protection against blood clotting without the risk of significant bleeding.

It was exciting but it was a challenge, and very different to an academic research project

—Professor Helen Philippou

Impact

• Knowledge discovery: created new blood clot prevention treatment and a University spin-out to take it to the market

Key information

• Major funders: Medical Research Council Development Pathway Funding Scheme, British Heart Foundation, Wellcome Trust Seeding Drug Discovery Initiative
  
• Disciplines: medicine, chemistry
• Investigators: Professor Helen Philippou, Dr Richard Foster

This project was sponsored by the UKRI Impact Acceleration Account.

Keywords: healthcare, medicine, business, innovation, healthtech, treatment, cardiology, hematology